Blog – Page 324

FDA Approves Igalmi (Dexmedetomidine) Sublingual Film

By ApoThera April 16, 2022Blog

Drug Info: ApoThera Drug Disease Clinical Support App - Assess vital signs including orthostatic measurements before administering Mild or Moderate Schizophrenia Agitation - 120 mcg SL or BUC x 1 dose…

Drug Information for Paxlovid (Nirmatrelvir-Ritonavir), Oral Medications for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application

By ApoThera April 9, 2022Blog

Drug Info: ApoThera Drug Disease Clinical Support App Nirmatrelvir-Ritonavir (Paxlovid) - 300 mg nirmatrelvir + 100 mg Ritonavir by mouth twice daily x 5 days - Initiate as soon as…

Drug Info for Lagevrio (Molnupiravir), Oral Medication for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application

By ApoThera April 9, 2022Blog

Drug Information for Oral Medications for the Treatment of Mild-to-Moderate COVID-19, Paxlovid (Nirmatrelvir-Ritonavir) and Molnupiravir (Lagevrio), Available on ApoThera Clinical Decision Support Mobile Application Drug Info: ApoThera Drug Disease Clinical…

Drug Information for COVID-19 Monoclonal Antibodies (Bebtelovimab) and Evusheld (Tixagevimab-Cilgavimab)

By ApoThera April 8, 2022Blog

Drug Info: ApoThera Drug Disease Clinical Support App Drug Info: ApoThera Drug Disease Clinical Support App Drug Information for COVID-19 Monoclonal Antibodies (Bebtelovimab) and COVID-19 Polyclonal Antibody Evusheld (Tixagevimab-Cilgavimab) Available…

FDA Approves Igalmi (Dexmedetomidine) Sublingual Film

Drug Information for Paxlovid (Nirmatrelvir-Ritonavir), Oral Medications for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application

Drug Info for Lagevrio (Molnupiravir), Oral Medication for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application

Drug Information for COVID-19 Monoclonal Antibodies (Bebtelovimab) and Evusheld (Tixagevimab-Cilgavimab)

FDA Pulls Authorization for GSK-Vir’s COVID Therapy, Sotrovimab, as BA.2 Cases Rise

Monoclonal Antibodies for Treating Severe Asthma

COVID-19 PCR Test, COVID-19 Antigen Test and COVID-19 Antibody Test

Tezspire (Tezepelumab), Monoclonal Antibody for the Treatment of Severe Asthma

Opdualag (Nivolumab-Relatlimab), for the Treatment of Melanoma

COVID-19 Viral Load, Onset of Symptoms Timeline & Antibody Response